Molecular mechanism of interleukin-8 gene expression

J Leukoc Biol. 1994 Nov;56(5):554-8.

Abstract

A potent leukocyte chemotactic and activating cytokine, interleukin-8 (IL-8), is produced by numerous types of cells in response to inflammatory stimuli. Accumulating evidence indicate that the transcription of IL-8 gene requires the activation of either the combination of NF-kappa B and AP-1 or that of NF-kappa B and NF-IL6, depending on the type of cells. Alternatively, the activation of NF-kappa B is indispensable for IL-8 gene activation in any types of cells examined. On the other hand, an immunosuppressant, FK506, and a glucocorticoid inhibit the gene transcription as well as the production of IL-8. Molecular analyses of IL-8 gene repression by these agents revealed that both affected the activity of the transcription factor(s) bound to the NF-kappa B site, albeit in different ways, thereby suppressing IL-8 gene transcription. Collectively, IL-8 production seems to be controlled mainly at the activation step of the transcription factor(s) bound to the NF-kappa B site.

MeSH terms

  • CCAAT-Enhancer-Binding Proteins
  • Chloramphenicol O-Acetyltransferase / genetics
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Dexamethasone / pharmacology
  • Electrophoresis
  • Gene Expression Regulation* / drug effects
  • Genes, Reporter
  • Humans
  • Interleukin-1 / pharmacology
  • Interleukin-8 / genetics*
  • Interleukin-8 / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Tacrolimus / pharmacology
  • Transcriptional Activation
  • Tumor Cells, Cultured

Substances

  • CCAAT-Enhancer-Binding Proteins
  • DNA-Binding Proteins
  • Interleukin-1
  • Interleukin-8
  • NF-kappa B
  • Nuclear Proteins
  • RNA, Messenger
  • Dexamethasone
  • Chloramphenicol O-Acetyltransferase
  • Tacrolimus